Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Debt Growth & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Debt Growth

LCTX Debt Growth

Latest reported-3.78%period endingDec 31, 2025

LCTX FY Debt Growth (YoY) (0.00% → -3.78%)

Latest values, visible window

High-resolution chart · PNG

LCTX debt growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Debt Growth — Annual fiscal periods
Period ending	Debt Growth
Dec 31, 2025	-3.7788%
Dec 31, 2024	-14.8374%
Dec 31, 2023	-24.23%
Dec 31, 2022	39.0435%
Dec 31, 2021	-26.7451%
Dec 31, 2020	-25.9868%
Dec 31, 2019	128.1678%
Dec 31, 2018	47.7495%
Dec 31, 2017	-61.5018%
Dec 31, 2016	-21.9675%
Dec 31, 2015	868.2965%
Dec 31, 2014	0%
Dec 31, 2013	0%
Dec 31, 2012	0%
Dec 31, 2011	0%
Dec 31, 2010	0%
Dec 31, 2009	-100%
Dec 31, 2008	163.1684%
Dec 31, 2007	0%
Dec 31, 2006	0%
Dec 31, 2005	0%
Dec 31, 2004	-100%
Dec 31, 2003	23.819%
Dec 31, 2002	25.2831%
Dec 31, 2001	0%
Dec 31, 2000	0%
Dec 31, 1999	0%
Dec 31, 1998	0%
Jun 30, 1998	0%
Jun 30, 1996	0%
Jun 30, 1995	0%
Jun 30, 1994	0%
Jun 30, 1993	0%
Jun 30, 1992	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.